Tominersen in Adults with Manifest Huntington's Disease
NEW ENGLAND JOURNAL OF MEDICINE（2023）
摘要
A trial of tominersen, designed to slow Huntington's disease progression by lowering levels of huntingtin protein, was stopped prematurely, and an ad hoc analysis of the results at week 69 was carried out.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要